首页|益气养阴明目方联合丹参注射液治疗非增生性糖尿病视网膜病变患者的效果

益气养阴明目方联合丹参注射液治疗非增生性糖尿病视网膜病变患者的效果

扫码查看
目的:观察益气养阴明目方联合丹参注射液治疗非增生性糖尿病视网膜病变(NPDR)患者的效果.方法:选取 2021 年3 月至 2023 年 3 月该院收治的 124 例NPDR患者进行前瞻性研究,采用随机数字表法将其分为对照组与观察组各 62 例.对照组采用丹参注射液治疗,观察组在对照组基础上联合益气养阴明目方治疗.比较两组临床疗效、治疗前后中医证候积分、血液流变学指标水平、眼底相关指标水平和不良反应发生率.结果:观察组治疗总有效率为 93.55%(58/62),高于对照组的 80.65%(50/62),差异有统计学意义(P<0.05);治疗后,两组目睛干涩、视物模糊、气短少言、神疲乏力、口咽干燥、自汗等中医证候积分均低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05);两组红细胞聚集指数、血浆黏度、全血高切黏度、全血低切黏度均低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05);两组微血管瘤个数均少于治疗前,且观察组少于对照组,两组血管渗漏面积、毛细血管无灌注区面积均小于治疗前,且观察组小于对照组,两组视网膜循环时间均短于治疗前,且观察组短于对照组,差异有统计学意义(P<0.05);治疗期间,两组均未见明显不良反应.结论:益气养阴明目方联合丹参注射液治疗NPDR患者可提高治疗总有效率,降低中医证候积分、血液流变学指标水平,改善眼底相关指标水平,其效果优于单纯丹参注射液治疗.
Effects of Yiqi Yangyin Mingmu prescription combined with Danshen injection in treatment of patients with non-proliferative diabetic retinopathy
Objective:To observe effects of Yiqi Yangyin Mingmu prescription combined with Danshen injection in treatment of patients with non-proliferative diabetic retinopathy(NPDR).Methods:A prospective study was conducted on 124 patients with NPDR admitted to the hospital from March 2021 to March 2023.They were divided into control group and observation group by using the random number table method,62 cases in each group.The control group was treated with Danshen injection,while the observation group was treated with Yiqi Yangyin Mingmu prescription on the basis of that of the control group.The clinical efficacy,the TCM syndrome score,the hemorheology index levels,the fundus related index levels,and the incidence of adverse reactions were compared between the two groups before and after the treatment.Results:The total effective rate of the observation group was 93.55%(58/62),which was higher than 80.65%(50/62)of the control group,and the difference was statistically significant(P<0.05).After the treatment,the scores of TCM syndromes such as dry eyes,blurred vision,shortness of breath,fatigue,oropharyngeal dryness and spontaneous sweating in the two groups were lower than those before the treatment,those in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).The levels of erythrocyte aggregation index,plasma viscosity,whole blood high shear viscosity and whole blood low shear viscosity of the two groups were lower than those before the treatment,those in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).The number of microaneurysms in the two groups were less than those before the treatment,and that in the observation group was less than that in the control group;the area of vascular leakage and the area of capillary non-perfusion area in the two groups were smaller than those before the treatment,and those in the observation group were smaller than those in the control group;the retinal circulation time of the two groups was shorter than that before the treatment,and that in the observation group was shorter than that in the control group;and the differences were statistically significant(P<0.05).During the treatment,there were no obvious adverse reactions in the two groups.Conclusions:Yiqi Yangyin Mingmu prescription combined with Danshen injection in the treatment of the NPDR patients can improve the total effective rate of treatment,reduce the TCM syndrome scores and the levels of hemorheological indexes,and improve the levels of fundus related indexes.Moreover,it is superior to single Danshen injection treatment.

Non-proliferative diabetic retinopathyYiqi Yangyin Mingmu prescriptionDanshen injectionTCM syndrome scoreHemorheologyFundusAdverse reaction

张达臻、杭丹丹、娄赟

展开 >

开封市中医院眼科,河南 开封 475000

非增生性糖尿病视网膜病变 益气养阴明目方 丹参注射液 中医证候积分 血液流变学 眼底 不良反应

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(1)
  • 15